Abstract
Spondylocostal dysostosis (SCDO) is a heterogeneous group of skeletal disorders characterized by multiple segmentation defects involving vertebrae and ribs. Seven disease genes have been reported as causal genes for SCDO: DLL3, MESP2, TBX6, HES7, RIPPLY2, DMRT2, and LFNG. Here we report a Japanese SCDO case with multiple severe vertebral anomalies from cervical to sacral spine. The patient was a compound heterozygote for c.372delG (p.K124Nfs*) and c.601G>A (p.D201N) variants of LFNG, which encodes a glycosyltransferase (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). The missense variant was in the DxD motif, an active-site motif of the glycosyltransferase, and its loss of the enzyme function was confirmed by an in vitro enzyme assay. This is the second report of LFNG mutations in SCDO.
Introduction
Spondylocostal dysostosis (SCDO) is a heterogeneous group of rare congenital disorders characterized by multiple segmentation defects of vertebrae (SDV) and malformation and/or defect of ribs. SDV of SCDO presented with hemi-vertebrae, butterfly vertebrae, fusion, absence, and block and mixed vertebrae. SCDO patients have short neck, short trunk, and scoliosis, and sometimes present with thoracic insufficiency syndrome caused by reduced size of thorax [1, 2].
Seven types of SCDO have been identified based on their phenotypes and disease genes: SCDO1 (OMIM#277300) due to DLL3 mutations [3], SCDO2 (OMIM#608681) due to MESP2 mutations [4], SCDO3 (OMIM#609813) due to a LFNG mutation [5], SCDO4 (OMIM#613868) due to HES7 mutations [6], SCDO5 (OMIM#122600) due to TBX6 mutations [7], and SCDO6 (OMIM#616566) due to RIPPLY2 mutations [8]. Recently, a case of SCDO due to a homozygous DMRT2 mutation has been reported [9]. All but SCDO5 are autosomal recessive traits. Autosomal dominant and autosomal recessive inheritance have been reported in TBX6 mutations [7, 10]. TBX6 mutations have also been reported in congenital scoliosis, a relatively common congenital disorder of the spine which has overlapping phenotypes with SCDO [7, 11].
Here, we report on a case of SCDO caused by compound heterozygous LFNG mutations. This is the second SCDO case with LFNG mutations. Both mutations we identified were novel and resulted in loss of LFNG function.
A 9-month-old Japanese boy was referred to us because of spinal deformity. His family history was unremarkable. Both parents had no apparent deformities. His height was about −2.5 SD. He had multiple vertebral anomalies from cervical to sacral vertebrae as well as defect and fusion of ribs (Fig. 1). There was no scoliosis and dysplasia of tubular bones. He had no respiratory problem, hand abnormalities, and other comorbidities, except for inguinal herniation. Based on the radiographic features, he was diagnosed as having SCDO, most likely SCDO3.
We sought the mutation of the patient. Informed consent was obtained from the patient’s parents. The study was approved by the ethical committee of all participating hospitals and RIKEN. Genomic DNAs were extracted from peripheral blood leukocytes of the patient and nails of his parents. We examined SCDO genes by direct sequencing using a 3730xl DNA analyzer (Applied Biosystems). The primer sequences are available on request. Genetyx (Genetyx, Tokyo, Japan) was used for aligning sequencing chromatographs to reference sequences (NM_001040167.1). The patient had two likely pathogenic variants in LNFG: c.372delG (p.K124Nfs*) in exon 1 and c.601G>A (p.D201N) in exon 4 (Fig. 2a, b). The former came from the mother and the latter from the father. We did not identify any likely disease-causing variants in other SCDO genes.
The two variants (c.372delG and c.601G>A) were absent from ExAC (Exome Aggregation Consortium, http://exac.broadinstitute.org), esp6500 (NHLBI Exome Sequencing Project, http://evs.gs.washington.edu/EVS), iJGVD (Integrative Japanese Genome Variation Database, https://ijgvd.megabank.tohoku.ac.jp), and HGVD (Human Genetic Variation database, http://www.hgvd.genome.med.kyoto-u.ac.jp/index.html) databases (Table 1). c.372delG (p.K124Nfs*21) was considered to cause nonsense-mediated mRNA decay (NMD). c.301G>A (p.D201N) was predicted to be pathogenic by bioinformatics prediction tools (Table 1). LFNG is a member of the Fringe gene family which includes MFNG and RFNG. They encode evolutionarily conserved glycosyltransferases that modify Notch and its ligands in the Golgi and act to determine boundaries during somitogenesis [12, 13]. p.D201 was located in the DxD motif which is highly conserved within the Fringe family (Fig. 2c) and in all known Fringe proteins from Drosophila melanogaster to human [5, 14, 15]. The motif is the catalytic site of many nucleoside disphosphate-binding glycosyltransferases [16, 17]. A previous study reported that a single amino acid alteration in the DxD motif disrupted all Fringe activities [18].
To confirm the pathogenicity of c.301G>A (p.D201N) variant, we assayed the GlcNAc-transferase activity of the p.D201N mutant protein in vitro. An expression vector of human LFNG was constructed as described previously [19] with slight modifications. Site-specific mutagenesis to produce p.D201N-LFNG was performed by using Inverse PCR-based site-directed mutagenesis (TOYOBO). The expression plasmids were transfected into HEK293T cells using FuGENE HD (Promega, Madison, WI). The conditioned media and cell lysates were collected 3 days after transfection and analyzed by western blotting after an electroporesis on a 10% sodium dodecyl sulfate–polyacrylamide gel using peroxidase-conjugated anti-DYKDDDDK antibody (Wako, Osaka, Japan) (Fig. 3a). The amount of recombinant LFNG protein was estimated by the standard curve from luminescent intensity of 3xFLAG-tagged bovine alkaline phosphatase (Sigma) using ImageQuant TL (GE Healthcare). GlcNAc-transferase activity was examined as described previously [19]. The mutant LFNG showed a significantly reduced GlcNAc-transferase activity compared to that of the wild-type LFNG (Fig. 3b), indicating that c.301G>A (p.D201N) variant lost its enzyme function.
To our knowledge, only one LFNG mutation has been reported previously [5]: Sparrow et al. [5] found a homozygous missense mutation, c.564C>A (p.F188L) in exon 3 of LFNG in a Lebanese patient with SCDO. The patient had extensive congenital vertebral anomalies and hand anomalies. Both parents heterozygous for the mutant allele had no spine and hand anomalies. p.F188 was a highly conserved residue (Fig. 2c). The mutant LFNG was not localized to the correct compartment of the cell, was unable to modulate Notch signaling in a cell-based assay, and was enzymatically inactive. The loss of LFNG function is likely pathogenesis of SCDO. Lfng-null mice show vertebral and ribs abnormalities due to the disruption of somitogenesis [20].
In the present study, we identified two novel mutations, c.372delG (p.K124Nfs*) and c.601G>A (p.D201N), which were compound heterozygous in a Japanese SCDO patient. Both mutations were also considered to cause loss of LFNG function, although their causal mechanisms were not mis-localization of the mutant LFNG protein, but loss of protein by NMD (p.K124Nfs*) and loss of the enzyme activity (p.D201N). The patient had severe vertebral anomalies from cervical to sacral spines, which are similar to previously reported SCDO with LFNG mutation. It is reported that SCDO3 had more severely disorganized spine than SCD1 and SCD2 [3,4,5]. Unlike the previous case [5], the present case did not have hand anomalies. Further accumulations of the cases with LFNG mutations are necessary to clarify the range of SCDO3 phenotype.
References
Karnes PS, Day D, Berry SA, Pierpont ME. Jarcho-Levin syndrome: four new cases and classification of subtypes. Am J Med Genet. 1991;40:264–70.
Turnpenny PD, Alman B, Cornier AS, Giampietro PF, Offiah A, Tassy O, et al. Abnormal vertebral segmentation and the notch signaling pathway in man. Dev Dyn. 2007;236:1456–74.
Bulman MP, Kusumi K, Frayling TM, McKeown C, Garrett C, Lander ES, et al. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet. 2000;24:438–41.
Whittock NV, Sparrow DB, Wouters MA, Sillence D, Ellard S, Dunwoodie SL, et al. Mutated MESP2 causes spondylocostal dysostosis in humans. Am J Hum Genet. 2004;74:1249–54.
Sparrow DB, Chapman G, Wouters MA, Whittock NV, Ellard S, Fatkin D, et al. Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. Am J Hum Genet. 2006;78:28–37.
Sparrow DB, Guillen-Navarro E, Fatkin D, Dunwoodie SL. Mutation of Hairy-and-Enhancer-of-Split-7 in humans causes spondylocostal dysostosis. Hum Mol Genet. 2008;17:3761–6.
Wu N, Ming X, Xiao J, Wu Z, Chen X, Shinawi M, et al. TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N Engl J Med. 2015;372:341–50.
McInerney-Leo AM, Sparrow DB, Harris JE, Gardiner BB, Marshall MS, O’Reilly VC, et al. Compound heterozygous mutations in RIPPLY2 associated with vertebral segmentation defects. Hum Mol Genet. 2015;24:1234–42.
Bouman A, Waisfisz Q, Admiraal J, van de Loo M, van Rijn RR, Dimitra M, et al. Homozygous DMRT2 variant associates with severe rib malformations in a newborn. Am J Med Genet A. 2018;176:1216–21.
Sparrow DB, McInerney-Leo A, Gucev ZS, Gardiner B, Marshall M, Leo PJ, et al. Autosomal dominant spondylocostal dysostosis is caused by mutation in TBX6. Hum Mol Genet. 2013;22:1625–31.
Takeda K, Kou I, Kawakami N, Iida A, Nakajima M, Ogura Y, et al. Compound heterozygosity for null mutations and a common hypomorphic risk haplotype in TBX6 causes congenital scoliosis. Hum Mutat. 2017;38:317–23.
Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, et al. Fringe is a glycosyltransferase that modifies Notch. Nature. 2000;406:369–75.
Serth K, Schuster-Gossler K, Kremmer E, Hansen B, Marohn-Kohn B, Gossler A. O-fucosylation of DLL3 is required for its function during somitogenesis. PLoS One. 2015;10:e0123776.
Correia T, Papayannopoulos V, Panin V, Woronoff P, Jiang J, Vogt TF, et al. Molecular genetic analysis of the glycosyltransferase Fringe in Drosophila. Proc Natl Acad Sci USA. 2003;100:6404–9.
Luther KB, Schindelin H, Haltiwanger RS. Structural and mechanistic insights into lunatic fringe from a kinetic analysis of enzyme mutants. J Biol Chem. 2009;284:3294–305.
Wiggins CA, Munro S. Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc Natl Acad Sci USA. 1998;95:7945–50.
Gastinel LN, Cambillau C, Bourne Y. Crystal structures of the bovine beta4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose. EMBO J. 1999;18:3546–57.
Munro S, Freeman M. The notch signalling regulator fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DXD. Curr Biol. 2000;10:813–20.
Rampal R, Li AS, Moloney DJ, Georgiou SA, Luther KB, Nita-Lazar A, et al. Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats. J Biol Chem. 2005;280:42454–63.
Evrard YA, Lun Y, Aulehla A, Gan L, Johnson RL. Lunatic fringe is an essential mediator of somite segmentation and patterning. Nature. 1998;394:377–81.
Acknowledgements
This study was supported by research grants from the Japan Orthopaedics and Traumatology Foundation (for NO. and KT), Japan Agency For Medical Research and Development (AMED) (contract Nos. 17ek0109212h0001 and 17ek0109280h0001 for SI), the Japan Society for the Promotion of Science (WAKATE B, No. 17K16710 for LG), the Cooperative Research Program (Joint Usage/Research Center program) of Institute for Frontier Life and Medical Sciences, Kyoto University (for SI and LG), and the Japan Society for the Promotion of Science (for SM., No. 16K08251).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Otomo, N., Mizumoto, S., Lu, HF. et al. Identification of novel LFNG mutations in spondylocostal dysostosis. J Hum Genet 64, 261–264 (2019). https://doi.org/10.1038/s10038-018-0548-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-018-0548-2
This article is cited by
-
Molecular landscape of congenital vertebral malformations: recent discoveries and future directions
Orphanet Journal of Rare Diseases (2024)
-
Identification of a novel LFNG variant in a Chinese fetus with spondylocostal dysostosis and a systematic review
Journal of Human Genetics (2024)